Commentary on King-Kallimanis et al.: Inadequate measurement of symptomatic adverse events in immunotherapy registration trials
- PMID: 30895807
- DOI: 10.1177/1740774519836989
Commentary on King-Kallimanis et al.: Inadequate measurement of symptomatic adverse events in immunotherapy registration trials
Comment on
-
Patient reported outcomes in anti-PD-1/PD-L1 inhibitor immunotherapy registration trials: FDA analysis of data submitted and future directions.Clin Trials. 2019 Jun;16(3):322-326. doi: 10.1177/1740774519836991. Epub 2019 Mar 18. Clin Trials. 2019. PMID: 30880446
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
